Boone Capital Management LLC
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Boone Capital Management LLC reported 21 stock positions worth $494.4 million. Its top holding was Unum (UNM) at 11.1% of the portfolio, followed by Cigna (CI, 9.7%) and Molina Healthcare (MOH, 7.1%). Compared with Q4 2023, it opened 3 new positions, sold out of 3, added to 11 and reduced 4. The biggest buy was a new position in Viking Therapeutics (VKTX) and the biggest sale an exit from Amgen (AMGN).
- Most Recent 13F
- Q2 2026
- Location
- ATLANTA, GA
- CIK
- 0001882053
- Portfolio Value
- $494.4M (Q1 2024)
- SEC Filing
- 0001214659-24-009294 ↗ filed May 15, 2024
Holdings Value
Holdings 21 stocks · $494.4M
| UNM Unum Group | 11.12% | 1,025,027 | $55.0M | Add +6.6% |
| CI The Cigna Group | 9.69% | 131,926 | $47.9M | Add +47.2% |
| MOH Molina Healthcare Inc. | 7.12% | 85,716 | $35.2M | Add +25.5% |
| ENOV Enovis Corp. | 7.11% | 562,739 | $35.1M | No change |
| BAX Baxter International Inc. | 6.03% | 697,957 | $29.8M | Add +27.2% |
| GMED Globus Medical Inc. Class A | 5.75% | 529,825 | $28.4M | No change |
| BERY Berry Global Group Inc. | 5.51% | 450,101 | $27.2M | Add +94.5% |
| AMPH Amphastar Pharmaceuticals Inc. | 5.39% | 606,688 | $26.6M | Add +51.7% |
| VKTX Viking Therapeutics Inc. | 5.15% | 310,462 | $25.5M | New |
| BIO Bio-Rad Laboratories-A | 5.06% | 72,344 | $25.0M | Add +102.6% |
| IDYA Ideaya Biosciences Inc. | 4.72% | 531,967 | $23.3M | No change |
| TARS Tarsus Pharmaceuticals Inc. | 4.48% | 609,104 | $22.1M | New |
| DHR Danaher Corp. | 3.32% | 65,811 | $16.4M | Reduce -39.4% |
| MLAB Mesa Laboratories Inc. | 2.96% | 133,394 | $14.6M | Add +108.2% |
| OFIX Orthofix Medical Inc. | 2.86% | 974,502 | $14.1M | Add +94.9% |
| VTRS Viatris Inc. | 2.74% | 1,133,591 | $13.5M | Reduce -40.7% |
| XENE Xenon Pharmaceuticals Inc. | 2.54% | 291,403 | $12.5M | Add +14.1% |
| HCSG Healthcare Services Group | 2.34% | 926,455 | $11.6M | New |
| MIRM Mirum Pharmaceuticals Inc. | 2.30% | 451,898 | $11.4M | Reduce -7.8% |
| PNTG The Pennant Group Inc. | 2.24% | 564,192 | $11.1M | Add +71.1% |
| QTRX Quanterix Corp. | 1.57% | 330,151 | $7.8M | Reduce -41.9% |
Portfolio Sells Q4 2023 → Q1 2024
| AMGN Amgen Inc. | Sold out | 0.00% | −6.82 |
| CVS CVS Health Corp. | Sold out | 0.00% | −6.77 |
| BBIO Bridgebio Pharma Inc. | Sold out | 0.00% | −4.15 |
| DHR Danaher Corp. | Reduce -39.4% | 3.32% | −2.53 |
| VTRS Viatris Inc. | Reduce -40.7% | 2.74% | −2.10 |
| QTRX Quanterix Corp. | Reduce -41.9% | 1.57% | −2.05 |
| MIRM Mirum Pharmaceuticals Inc. | Reduce -7.8% | 2.30% | −1.08 |
Portfolio Buys Q4 2023 → Q1 2024
| VKTX Viking Therapeutics Inc. | New | 5.15% | +5.15 |
| TARS Tarsus Pharmaceuticals Inc. | New | 4.48% | +4.48 |
| CI The Cigna Group | Add +47.2% | 9.69% | +3.43 |
| BIO Bio-Rad Laboratories-A | Add +102.6% | 5.06% | +2.37 |
| HCSG Healthcare Services Group | New | 2.34% | +2.34 |
| BERY Berry Global Group Inc. | Add +94.5% | 5.51% | +1.87 |
| MLAB Mesa Laboratories Inc. | Add +108.2% | 2.96% | +1.39 |
| MOH Molina Healthcare Inc. | Add +25.5% | 7.12% | +1.36 |
| OFIX Orthofix Medical Inc. | Add +94.9% | 2.86% | +1.29 |
| PNTG The Pennant Group Inc. | Add +71.1% | 2.24% | +1.17 |
| BAX Baxter International Inc. | Add +27.2% | 6.03% | +1.08 |
| UNM Unum Group | Add +6.6% | 11.12% | +0.97 |
| XENE Xenon Pharmaceuticals Inc. | Add +14.1% | 2.54% | −0.21 |
| AMPH Amphastar Pharmaceuticals Inc. | Add +51.7% | 5.39% | −0.39 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 16 | $427.5M | TFX, MIRM, CI, IONS, UNH |
| Q1 2026 | 13 | $326.4M | MIRM, IONS, CI, MDT, TFX |
| Q4 2025 | 15 | $318.6M | MDT, MIRM, IONS, CI, BMRN |
| Q3 2025 | 16 | $305.0M | MDT, MIRM, IONS, CI, BBIO |
| Q2 2025 | 11 | $233.2M | MDT, MIRM, BMRN, AVTR, UNM |
| Q1 2025 | 12 | $293.8M | UNM, MDT, MIRM, GMED, CI |
| Q4 2024 | 13 | $296.5M | UNM, GMED, PRGO, MIRM, MOH |
| Q3 2024 | 17 | $385.8M | UNM, GMED, CI, MOH, CHE |
| Q2 2024 | 19 | $383.4M | UNM, GMED, CI, MOH, DHR |
| Q1 2024 | 21 | $494.4M | UNM, CI, MOH, ENOV, BAX |